Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track IBO with free AI briefings, catalyst countdowns, and dilution alerts.

IBO

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$3,000 Cash on Hand

1mo Cash Runway

11.2% Short Interest

🧪 Upcoming Trial Catalysts

2026-08-01 · Phase 3 — Active Trial — A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Mod
2026-10-31 · NA — Recruiting — Physical Exam, Static & Dynamic Ultrasound Assessment, & Treatment of Thoracolumbar Fascia
2026-12-31 · NA — Recruiting — Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangi
2027-01-30 · Phase 3 — Active Trial — A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Indu
2027-02-23 · N/A — Recruiting — Clinical Study of PEG Bowel Preparation in Appendectomy Patients
2027-03-31 · Phase 2 — Upcoming Trial — Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

💰 Cash Runway & Dilution Risk

IBO holds $3,000 in cash and burns about $9,000/quarter from operations, giving an estimated runway of 1 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for IBO free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-01-06	DSS, INC.	Sale	$324,202
2026-01-06	DSS, INC.	Sale	$294,476
2025-05-27	DSS, INC.	Sale	$24,929
2025-05-27	DSS, INC.	Sale	$0
2025-04-07	Chan Heng Fai Ambrose	Sale	$0

Get the full IBO picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for IBO and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z